There are deep-rooted regional inequalities in health and wealth across England. ‘Levelling Up’ is the UK Government’s flagship policy to redress these inequalities through additional investment, with the Community Renewal Fund (CRF) one strand of this funding. In this article, Christine Camacho and Dr Luke Munford examine the allocation of the first round of the […]
Long in the tooth: is water fluoridation out of date?
One ongoing intervention to tackle tooth decay in parts of the UK is the provision of fluoride in drinking water. But such moves aren’t always popular with the communities involved. There is also a lack of evidence based on contemporary populations. Here, Dr Michaela Goodwin and Professor Michael Kelly outline the findings of a new […]
Global partnerships: How can international research collaborations boost our health and economy?
The University of Manchester is a founding partner of the Kenya-UK Healthcare Alliance, which aims to share best practice and reciprocal training between the two nations, particularly in the area of cancer care. In this article, from our On Cancer publication, Professor Keith Brennan, Dr F. George Njoroge, and Professor Rob Bristow outline how these […]
Health inequalities and regional productivity
The health of those living in the north is worse than those living in the south, and this inequality is reflected in the comparative economic performance as well. The regional inequality in economic performance is prominent throughout the United Kingdom. In this blog, Dr Luke Munford and Professor Clare Bambra explore the links between health […]
Child of the North: The economic impacts of child health
The economic performance of the North of England consistently lags behind the national average. One factor that could partly explain this ‘productivity gap’ is the poorer physical and mental health of children in the North, along with a widening educational gap, with long-lasting impacts on the labour market. In this blog, Dr Rose Atkins and […]
Saving lives and money through early detection: Lynch syndrome case study
A new national standard for cancer testing in England and Wales (NICE ‘Diagnostic Guidance 42’) was published in October 2020, following a successful policy engagement campaign from Professor Emma Crosbie’s team at The University of Manchester, and Policy@Manchester. In this piece, adapted from our On Cancer publication, Professor Crosbie explains why this is just the […]
All sorted now? The continued risk of COVID-19 to patients with severe mental illness
The success of the coronavirus vaccine rollout in the UK and internationally has allowed some return to normality for many people. However, one group that was – and continues to be – at risk of being overlooked in the context of COVID-19 is those with severe mental illness (SMI). In this blog, Dr Lamiece Hassan […]
Race equality in Greater Manchester: opportunities and challenges of collaboration
In 2021 the report of the Independent Inequalities Commission for Greater Manchester emphasised the need to put wellbeing and equality goals at the heart of the Greater Manchester Strategy. They recommended the development of a Race Equality Strategy. This led to a collaboration between the Greater Manchester Combined Authority (GMCA) and the Centre for Dynamics […]
Access and inclusion: Can we move cancer services closer to home?
Traditionally, the vast majority of cancer services take place in hospitals, but new thinking and new technology are rapidly changing this landscape, particularly because of the impact of COVID-19 on the delivery of healthcare services. In this blog, from our On Cancer publication, Dr Philip Crosbie and Dr Dónal Landers outlines how delivering services at […]
Disadvantage and disease: finding solutions to inequalities in cancer
The COVID-19 pandemic has brought renewed focus to the great health inequalities between different communities in our society. Looking at cancer care, these inequalities exist across the whole cancer pathway from uptake in screening, likelihood to present early with symptoms, participation in clinical trials, diagnosis and access to treatments. In this blog, from our On […]